(Q38224320)

31 August 2017

title

Advances in ocular drug delivery: emphasis on the posterior segment (English)

1 reference

31 August 2017

1 reference

Jennifer J Kang-Mieler

series ordinal

1

1 reference

31 August 2017

Christian R Osswald

series ordinal

2

1 reference

31 August 2017

William F Mieler

series ordinal

3

1 reference

31 August 2017

language of work or name

English

0 references

publication date

30 June 2014

1 reference

Expert Opinion on Drug Delivery

31 August 2017

published in

1 reference

31 August 2017

volume

11

1 reference

31 August 2017

issue

10

1 reference

31 August 2017

page(s)

1647-1660

1 reference

Novel approaches to retinal drug delivery

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Drug delivery systems for vitreoretinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Retinal and choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Intravitreal injection of therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Topical and systemic drug delivery to the posterior segments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Drug delivery to the retina: challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Cyclodextrins in ophthalmic drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Current ocular drug delivery challenges for N-acetylcarnosine: novel patented routes and modes of delivery, design for enhancement of therapeutic activity and drug delivery relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Contact lenses for antifungal ocular drug delivery: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Applications of liposomes in ophthalmology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Molecular design for enhancement of ocular penetration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Topical delivery of Avastin to the posterior segment of the eye in vivo using annexin A5-associated liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Structure of membrane-bound annexin A5 trimers: a hybrid cryo-EM - X-ray crystallography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Steroid eye drop treatment (difluprednate ophthalmic emulsion) is effective in reducing refractory diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

A drug-eluting contact lens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Verteporfin: a review of its use in the management of subfoveal choroidal neovascularisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Photodynamic therapy and combination treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Reduction of diabetic macular edema by oral administration of the kinase inhibitor PKC412.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Periocular Injection of Microspheres Containing PKC412 Inhibits Choroidal Neovascularization in a Porcine Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Metabolic basis of visual cycle inhibition by retinoid and nonretinoid compounds in the vertebrate retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Visual cycle modulation in neurovascular retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Phase 1, dose-ranging study of emixustat hydrochloride (ACU-4429), a novel visual cycle modulator, in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Biosynthetic studies of A2E, a major fluorophore of retinal pigment epithelial lipofuscin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Periocular routes for retinal drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Prodrug based optimal drug delivery via membrane transporter/receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Transport barriers in transscleral drug delivery for retinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Transcorneal and transscleral iontophoresis of dexamethasone phosphate using drug loaded hydrogel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Intraocular penetration of vancomycin eye drops after application to the medial canthus with closed lids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Canaloplasty: circumferential viscodilation and tensioning of Schlemm's canal using a flexible microcatheter for the treatment of open-angle glaucoma in adults: interim clinical study analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Pharmacokinetics of pars plana intravitreal injections versus microcannula suprachoroidal injections of bevacizumab in a porcine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Safety of submacular suprachoroidal drug administration via a microcatheter: retrospective analysis of European treatment results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Suprachoroidal drug delivery to the back of the eye using hollow microneedles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Intraocular implants for extended drug delivery: therapeutic applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Ranibizumab for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Pharmacotherapy for neovascular age-related macular degeneration: an analysis of the 100% 2008 medicare fee-for-service part B claims file

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Phase I study of intravenous vascular endothelial growth factor trap, aflibercept, in patients with advanced solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Visual and anatomic outcomes associated with posterior segment complications after ganciclovir implant procedures in patients with AIDS and cytomegalovirus retinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Ocular pharmacokinetics of fluocinolone acetonide after Retisert intravitreal implantation in rabbits over a 1-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Application of encapsulated cell technology for retinal degenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

The effects of cross-linked thermo-responsive PNIPAAm-based hydrogel injection on retinal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Objective area measurement technique for choroidal neovascularization from fluorescein angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Topical Dexamethasone-Cyclodextrin Microparticle Eye Drops for Diabetic Macular Edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

Hydrogel Contact Lens for Extended Delivery of Ophthalmic Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2014.935338

10.1517/17425247.2014.935338

21 January 2018

Identifiers

DOI

1 reference

31 August 2017

1 reference